Akwai sabuwar shaida cewa maganin rigakafin COVID-19 tabbatacce ga kamuwa da cuta da ya gabata zai rage haɗarin sake kamuwa da cuta a nan gaba.
Wani bincike da aka buga Laraba a cikin mujallar JAMA Internal Medicine ya gano cewa mutanen da suka gwada ingancin COVID-19 sun sami raguwar haɗarin kamuwa da cutar coronavirus idan aka kwatanta da waɗanda suka gwada rashin lafiyar ƙwayoyin cuta.
Dokta Douglas Lowy ya ce: “Sakamakon wannan binciken an rage shi da kashi 10, amma ina da wasu ƙwazo game da wannan.A wasu kalmomi, wannan yana iya zama ƙima na raguwa.Wannan na iya zama gaskiya.Rashin kimanta raguwar.”shi ne marubucin binciken kuma babban mataimakin darakta na Cibiyar Cancer ta kasa.
Ya ce: "A gare ni, an rage saƙo mafi girma.""Babban abin da ake ɗauka shine cewa ingantattun ƙwayoyin cuta bayan cututtukan yanayi suna da alaƙa da hana sabbin cututtuka."
Lowy ya kara da cewa mutanen da suka murmure daga COVID-19 ya kamata a yi musu allurar idan lokacinsu ya yi.
Masu bincike daga Cibiyar Cancer ta Kasa da kamfanoni irin su LabCorp, Quest Diagnostics, Aetion Inc. da HealthVerity sun yi nazarin bayanan sama da mutane miliyan 3.2 a Amurka wadanda suka kammala gwajin rigakafin COVID-19 tsakanin Janairu da Agustan bara.A cikin waɗannan gwaje-gwajen, 11.6% na ƙwayoyin rigakafin COVID-19 sun tabbata kuma 88.3% ba su da kyau.
A cikin bayanan da aka biyo baya, masu binciken sun gano cewa bayan kwanaki 90, kawai 0.3% na mutanen da suka gwada ingancin kwayoyin rigakafin COVID-19 a ƙarshe sun gwada ingancin kamuwa da cutar coronavirus.Daga cikin marasa lafiya da sakamakon gwajin rigakafin COVID-19 mara kyau, 3% daga baya an gano su da kamuwa da cutar coronavirus a daidai wannan lokacin.
Gabaɗaya, wannan binciken abin lura ne, kuma yana nuna alaƙa tsakanin tabbataccen sakamakon gwajin rigakafin cutar COVID-19 da raguwar haɗarin kamuwa da cuta bayan kwanaki 90-amma ana buƙatar ƙarin bincike don tantance musabbabin da kuma tsawon lokacin da ake kare rigakafin.
Roy ya ce ana buƙatar ƙarin bincike don tantance haɗarin sake kamuwa da cuta daga ɗayan bambance-bambancen coronavirus da ke fitowa.
Lowe ya ce: “Yanzu akwai waɗannan abubuwan da ke damuwa.Me suke nufi?Amsar mafi kankantar ita ce ba mu sani ba.”Ya kuma jaddada cewa mutanen da suka gwada ingancin kwayoyin cutar ya kamata a yi musu allurar rigakafin COVID-19.
Sanannen abu ne cewa yawancin marasa lafiya da ke murmurewa daga COVID-19 suna da ƙwayoyin rigakafi, kuma ya zuwa yanzu, reinfection da alama ba kasafai ba ne-amma "har yaushe kariyar rigakafin cutar za ta kasance saboda cututtukan yanayi" ya kasance ba a sani ba," Dr. Mitchell Katz + na Lafiya na NYC + Tsarin kula da lafiya na asibiti ya rubuta a cikin edita wanda aka buga tare da sabon bincike a cikin JAMA Internal Medicine.
Katz ya rubuta: "Saboda haka, ba tare da la'akari da matsayin antibody ba, ana ba da shawarar samun rigakafin SARS-CoV-2."SARS-CoV-2 shine sunan coronavirus wanda ke haifar da COVID-19.
Ya rubuta: "Ba a san tsawon lokacin kariyar rigakafin da allurar rigakafi ke bayarwa ba."“Ya zama dole a san tsawon lokacin da kariyar rigakafin ke daɗe saboda kamuwa da cuta ta halitta ko allurar rigakafi.Lokaci ne kawai zai nuna."
Hearst Television yana shiga cikin shirye-shiryen tallace-tallace na haɗin gwiwa daban-daban, wanda ke nufin cewa za mu iya karɓar kwamitocin biyan kuɗi don sayayya ta hanyar hanyoyin haɗin yanar gizon dillalai.
Lokacin aikawa: Fabrairu-25-2021